Jury Stuns Merck With $8M Verdict For Fosamax Plaintiff
Jurors returned a verdict in the U.S. District Court for the Southern District of New York after just a few hours of deliberations, finding the drug to be defectively designed for certain purposes and Merck negligent in failing to address risks associated with the medication.
"This is the world's bravest great-grandmother," Boles' attorney Timothy O'Brien said following the...
Already a subscriber? Click here to login